Production of biologically active complement factor H in therapeutically useful quantities

Protein Expression and Purification

Volumn 76, Issue 2, 2011, Pages 254-263

  Schmidt, Christoph Q ^a   Slingsby, Fern C ^a   Richards, Anna ^b   Barlow, Paul N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Age related macular degeneration; Atypical haemolytic uraemic syndrome; Dense deposit disease; Protein therapeutic; Synthetic gene

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN; RECOMBINANT PROTEIN; SYNTHETIC DNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; ERYTHROCYTE; GENETICS; HEMOLYSIS; HUMAN; LIGHT; MASS SPECTROMETRY; METABOLISM; PICHIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIATION SCATTERING; RETINA MACULA DEGENERATION; SHEEP; SINGLE NUCLEOTIDE POLYMORPHISM; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; COMPLEMENT C3B; COMPLEMENT FACTOR H; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; GENES, SYNTHETIC; HEMOLYSIS; HUMANS; LIGHT; MACULAR DEGENERATION; MASS SPECTROMETRY; PICHIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; SCATTERING, RADIATION; SHEEP; SURFACE PLASMON RESONANCE;

HEXAPODA; MAMMALIA; PICHIA PASTORIS;

EID: 79151485902     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.12.002     Document Type: Article

References (73)

1. R.B. Sim, and R.G. DiScipio Purification and structural studies on the complement-system control protein beta 1H (Factor H) Biochem. J. 205 1982 285 293
2. J. Ripoche, A.J. Day, A.C. Willis, K.T. Belt, R.D. Campbell, and R.B. Sim Partial characterization of human complement factor H by protein and cDNA sequencing: homology with other complement and non-complement proteins Biosci. Rep. 6 1986 65 72
3. J.M. Weiler, M.R. Daha, K.F. Austen, and D.T. Fearon Control of the amplification convertase of complement by the plasma protein beta1H Proc. Natl. Acad. Sci. USA 73 1976 3268 3272
4. F. Fenaille, M. Le Mignon, C. Groseil, C. Ramon, S. Riande, L. Siret, and N. Bihoreau Site-specific N-glycan characterization of human complement factor H Glycobiology 17 2007 932 944
5. D.C. Soares, and P.N. Barlow Complement control protein modules in the regulators of complement activation D. Morikis, J.D. Lambris, Structural Biology of the Complement System 2005 CRC Press Taylor & Francis Group, Boca Raton 19 62
6. T. Kristensen, and B.F. Tack Murine protein H is comprised of 20 repeating units, 61 amino acids in length Proc. Natl. Acad. Sci. USA 83 1986 3963 3967
7. M.K. Pangburn, R.D. Schreiber, and H.J. Muller-Eberhard Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution J. Exp. Med. 146 1977 257 270
8. S. Meri, and M.K. Pangburn Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H Proc. Natl. Acad. Sci. USA 87 1990 3982 3986
9. M.K. Pangburn Host recognition and target differentiation by factor H. A regulator of the alternative pathway of complement Immunopharmacology 49 2000 149 157
10. M.J. Walport Complement. Second of two parts N. Engl. J. Med. 344 2001 1140 1144
11. M.J. Walport Complement. First of two parts N. Engl. J. Med. 344 2001 1058 1066
12. M.K. Pangburn, and H.J. Muller-Eberhard The alternative pathway of complement Springer Semin Immunopathol. 7 1984 163 192
13. C.Q. Schmidt, A.P. Herbert, H.G. Hocking, D. Uhrin, and P.N. Barlow Translational Mini-Review Series on Complement Factor H: structural and functional correlations for factor H Clin. Exp. Immunol. 151 2008 14 24
14. C.Q. Schmidt, A.P. Herbert, D. Kavanagh, C. Gandy, C.J. Fenton, B.S. Blaum, M. Lyon, D. Uhrin, and P.N. Barlow A new map of glycosaminoglycan and C3b binding sites on factor H J. Immunol. 181 2008 2610 2619
15. S. Kuhn, C. Skerka, and P.F. Zipfel Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1 J. Immunol. 155 1995 5663 5670
16. M.K. Pangburn, M.A. Atkinson, and S. Meri Localization of the heparin-binding site on complement factor H J. Biol. Chem. 266 1991 16847 16853
17. S. Meri, and M.K. Pangburn Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H Biochem. Biophys. Res. Commun. 198 1994 52 59
18. V.P. Ferreira, A.P. Herbert, H.G. Hocking, P.N. Barlow, and M.K. Pangburn Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces J. Immunol. 177 2006 6308 6316
19. P. Warwicker, T.H. Goodship, R.L. Donne, Y. Pirson, A. Nicholls, R.M. Ward, P. Turnpenny, and J.A. Goodship Genetic studies into inherited and sporadic hemolytic uremic syndrome Kidney Int. 53 1998 836 844
20. M.A. Dragon-Durey, and V. Fremeaux-Bacchi Atypical haemolytic uraemic syndrome and mutations in complement regulator genes Springer Semin Immunopathol. 27 2005 359 374
21. A. Richards, M.R. Buddles, R.L. Donne, B.S. Kaplan, E. Kirk, M.C. Venning, C.L. Tielemans, J.A. Goodship, and T.H. Goodship Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20. A domain important for host cell recognition Am. J. Hum. Genet. 68 2001 485 490
22. D. Perez-Caballero, C. Gonzalez-Rubio, M.E. Gallardo, M. Vera, M. Lopez-Trascasa, S. Rodriguez de Cordoba, and P. Sanchez-Corral Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome Am. J. Hum. Genet. 68 2001 478 484
23. J. Caprioli, P. Bettinaglio, P.F. Zipfel, B. Amadei, E. Daina, S. Gamba, C. Skerka, N. Marziliano, G. Remuzzi, and M. Noris The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20 J. Am. Soc. Nephrol. 12 2001 297 307
24. M.A. Dragon-Durey, C. Loirat, S. Cloarec, M.A. Macher, J. Blouin, H. Nivet, L. Weiss, W.H. Fridman, and V. Fremeaux-Bacchi Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome J. Am. Soc. Nephrol. 16 2005 555 563
25. M. Jozsi, S. Strobel, H.M. Dahse, W.S. Liu, P.F. Hoyer, M. Oppermann, C. Skerka, and P.F. Zipfel Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome Blood 110 2007 1516 1518
26. M. Jozsi, C. Licht, S. Strobel, S.L. Zipfel, H. Richter, S. Heinen, P.F. Zipfel, and C. Skerka Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with FHR1/FHR3 deficiency Blood 111 2008 1512 1514
27. I. Moore, L. Strain, I. Pappworth, D. Kavanagh, P.N. Barlow, A.P. Herbert, C.Q. Schmidt, S.J. Staniforth, L.V. Holmes, R. Ward, L. Morgan, T.H. Goodship, and K.J. Marchbank Association of factor H autoantibodies with deletions of FHR1, FHR3, FHR4, and with mutations in FH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome Blood 115 2010 379 387
28. M.A. Dragon-Durey, V. Fremeaux-Bacchi, C. Loirat, J. Blouin, P. Niaudet, G. Deschenes, P. Coppo, W. Herman Fridman, and L. Weiss Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases J. Am. Soc. Nephrol. 15 2004 787 795
29. C. Licht, S. Heinen, M. Jozsi, I. Loschmann, R.E. Saunders, S.J. Perkins, R. Waldherr, C. Skerka, M. Kirschfink, B. Hoppe, and P.F. Zipfel Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II) Kidney Int. 70 2006 42 50
30. T. Montes, E. Goicoechea de Jorge, R. Ramos, M. Goma, O. Pujol, P. Sanchez-Corral, and S. Rodriguez de Cordoba Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis Mol. Immunol. 45 2008 2897 2904
31. M.C. Pickering, H.T. Cook, J. Warren, A.E. Bygrave, J. Moss, M.J. Walport, and M. Botto Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nat. Genet. 31 2002 424 428
32. J.H. Jansen, K. Hogasen, and A.M. Grondahl Porcine membranoproliferative glomerulonephritis type II: an autosomal recessive deficiency of factor H Vet. Rec. 137 1995 240 244
33. G.S. Hageman, D.H. Anderson, L.V. Johnson, L.S. Hancox, A.J. Taiber, L.I. Hardisty, J.L. Hageman, H.A. Stockman, J.D. Borchardt, K.M. Gehrs, R.J. Smith, G. Silvestri, S.R. Russell, C.C. Klaver, I. Barbazetto, S. Chang, L.A. Yannuzzi, G.R. Barile, J.C. Merriam, R.T. Smith, A.K. Olsh, J. Bergeron, J. Zernant, J.E. Merriam, B. Gold, M. Dean, and R. Allikmets A common haplotype in the complement regulatory gene factor H (HF1/FH) predisposes individuals to age-related macular degeneration Proc. Natl. Acad. Sci. USA 102 2005 7227 7232
34. R.J. Klein, C. Zeiss, E.Y. Chew, J.Y. Tsai, R.S. Sackler, C. Haynes, A.K. Henning, J.P. SanGiovanni, S.M. Mane, S.T. Mayne, M.B. Bracken, F.L. Ferris, J. Ott, C. Barnstable, and J. Hoh Complement factor H polymorphism in age-related macular degeneration Science 308 2005 385 389
35. A.O. Edwards, R. Ritter 3rd, K.J. Abel, A. Manning, C. Panhuysen, and L.A. Farrer Complement factor H polymorphism and age-related macular degeneration Science 308 2005 421 424
36. J.L. Haines, M.A. Hauser, S. Schmidt, W.K. Scott, L.M. Olson, P. Gallins, K.L. Spencer, S.Y. Kwan, M. Noureddine, J.R. Gilbert, N. Schnetz-Boutaud, A. Agarwal, E.A. Postel, and M.A. Pericak-Vance Complement factor H variant increases the risk of age-related macular degeneration Science 308 2005 419 421
37. A. Richards, D. Kavanagh, and J.P. Atkinson Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory states the examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration Adv. Immunol. 96 2007 141 177
38. A.M. Waters, and C. Licht aHUS caused by complement dysregulation: new therapies on the horizon Pediatr. Nephrol. 26 2011 41 57
39. W.K. Hoots History of plasma-product safety Transfus. Med. Rev. 15 2001 3 10
40. J. Carbone Adverse reactions and pathogen safety of intravenous immunoglobulin Curr. Drug Saf. 2 2007 9 18
41. A.K. Sharma, and M.K. Pangburn Biologically active recombinant human complement factor H: synthesis and secretion by the baculovirus system Gene 143 1994 301 302
42. A.K. Sharma, and M.K. Pangburn Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis Proc. Natl. Acad. Sci. USA 93 1996 10996 11001
43. P. Sanchez-Corral, D. Perez-Caballero, O. Huarte, A.M. Simckes, E. Goicoechea, M. Lopez-Trascasa, and S.R. De Cordoba Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome Am. J. Hum. Genet. 71 2002 1285 1295
44. A. Buttner-Mainik, J. Parsons, H. Jerome, A. Hartmann, S. Lamer, A. Schaaf, A. Schlosser, P.F. Zipfel, R. Reski, E.L. Decker, Production of biologically active recombinant human factor H in Physcomitrella. Plant Biotechnol J. (2010) in press.
45. B.E. Prosser, S. Johnson, P. Roversi, A.P. Herbert, B.S. Blaum, J. Tyrrell, T.A. Jowitt, S.J. Clark, E. Tarelli, D. Uhrin, P.N. Barlow, R.B. Sim, A.J. Day, and S.M. Lea Structural basis for complement factor H linked age-related macular degeneration J. Exp. Med. 204 2007 2277 2283
46. T.S. Jokiranta, V.P. Jaakola, M.J. Lehtinen, M. Parepalo, S. Meri, and A. Goldman Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome EMBO J. 25 2006 1784 1794
47. M.R. Eckart, and C.M. Bussineau Quality and authenticity of heterologous proteins synthesized in yeast Curr. Opin. Biotechnol. 7 1996 525 530
48. F.S. Hartner, and A. Glieder Regulation of methanol utilisation pathway genes in yeasts Microb. Cell Fact. 5 2006 39
49. A. Murasugi Secretory expression of human protein in the Yeast Pichia pastoris by controlled fermentor culture Recent Pat. Biotechnol. 4 2010 153 166
50. G.P. Cereghino, and J.M. Cregg Applications of yeast in biotechnology: protein production and genetic analysis Curr. Opin. Biotechnol. 10 1999 422 427
51. A. Sahu, S.N. Isaacs, A.M. Soulika, and J.D. Lambris Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway J. Immunol. 160 1998 5596 5604
52. T.S. Jokiranta, J. Westin, U.R. Nilsson, B. Nilsson, J. Hellwage, S. Lofas, D.L. Gordon, K.N. Ekdahl, and S. Meri Complement C3b interactions studied with surface plasmon resonance technique Int. Immunopharmacol. 1 2001 495 506
53. C.L. Harris, R.J. Abbott, R.A. Smith, B.P. Morgan, and S.M. Lea Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55) J. Biol. Chem. 280 2005 2569 2578
54. J. Wu, Y.Q. Wu, D. Ricklin, B.J. Janssen, J.D. Lambris, and P. Gros Structure of complement fragment C3b-factor H and implications for host protection by complement regulators Nat. Immunol. 10 2009 728 733
55. P. Sanchez-Corral, C. Gonzalez-Rubio, S. Rodriguez de Cordoba, and M. Lopez-Trascasa Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H Mol. Immunol. 41 2004 81 84
56. D. Kavanagh, R. Burgess, D. Spitzer, A. Richards, M.L. Diaz-Torres, J.A. Goodship, D.E. Hourcade, J.P. Atkinson, and T.H. Goodship The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation Mol. Immunol. 44 2007 3162 3167
57. R. Daly, and M.T. Hearn Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production J. Mol. Recognit. 18 2005 119 138
58. A.P. Wiles, G. Shaw, J. Bright, A. Perczel, I.D. Campbell, and P.N. Barlow NMR studies of a viral protein that mimics the regulators of complement activation J. Mol. Biol. 272 1997 253 265
59. B.O. Smith, R.L. Mallin, M. Krych-Goldberg, X. Wang, R.E. Hauhart, K. Bromek, D. Uhrin, J.P. Atkinson, and P.N. Barlow Structure of the C3b binding site of CR1 (CD35). The immune adherence receptor Cell 108 2002 769 780
60. H.G. Hocking, A.P. Herbert, D. Kavanagh, D.C. Soares, V.P. Ferreira, M.K. Pangburn, D. Uhrin, and P.N. Barlow Structure of the N-terminal region of complement factor h and conformational implications of disease-linked sequence variations J. Biol. Chem. 283 2008 9475 9487
61. D. Lorimer, A. Raymond, J. Walchli, M. Mixon, A. Barrow, E. Wallace, R. Grice, A. Burgin, and L. Stewart Gene composer: database software for protein construct design. Codon engineering, and gene synthesis BMC Biotechnol. 9 2009 36
62. M.C. dAnjou, and A.J. Daugulis A rational approach to improving productivity in recombinant Pichia pastoris fermentation Biotechnol. Bioeng. 72 2001 1 11
63. R. Ramon, P. Ferrer, and F. Valero Sorbitol co-feeding reduces metabolic burden caused by the overexpression of a Rhizopus oryzae lipase in Pichia pastoris J. Biotechnol. 130 2007 39 46
64. X. Huo, Y. Liu, X. Wang, P. Ouyang, Z. Niu, Y. Shi, and B. Qiu Co-expression of human protein disulfide isomerase (hPDI) enhances secretion of bovine follicle-stimulating hormone (bFSH) in Pichia pastoris Protein Expr. Purif. 54 2007 234 239
65. V.P. Ferreira, A.P. Herbert, C. Cortes, K.A. McKee, B.S. Blaum, S.T. Esswein, D. Uhrin, P.N. Barlow, M.K. Pangburn, and D. Kavanagh The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome J. Immunol. 182 2009 7009 7018
66. C.Q. Schmidt, A.P. Herbert, H.D. Mertens, M. Guariento, D.C. Soares, D. Uhrin, A.J. Rowe, D.I. Svergun, and P.N. Barlow The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module J. Mol. Biol. 395 2010 105 122
67. M.H. Jouvin, M.D. Kazatchkine, A. Cahour, and N. Bernard Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement J. Immunol. 133 1984 3250 3254
68. M.A. Abrera-Abeleda, C. Nishimura, J.L. Smith, S. Sethi, J.L. McRae, B.F. Murphy, G. Silvestri, C. Skerka, M. Jozsi, P.F. Zipfel, G.S. Hageman, and R.J. Smith Variations in the complement regulatory genes factor H (FH) and factor H related 5 (FHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) J. Med. Genet. 43 2006 582 589
69. V. Fremeaux-Bacchi, E.J. Kemp, J.A. Goodship, M.A. Dragon-Durey, L. Strain, C. Loirat, H.W. Deng, and T.H. Goodship The development of atypical HUS is influenced by susceptibility factors in factor H and membrane cofactor protein- evidence from two independent cohorts J. Med. Genet. 42 2005 852 856
70. W. Vervecken, N. Callewaert, V. Kaigorodov, S. Geysens, and R. Contreras Modification of the N-glycosylation pathway to produce homogeneous. Human-like glycans using GlycoSwitch plasmids Methods Mol. Biol. 389 2007 119 138
71. T.S. Young, I. Ahmad, A. Brock, and P.G. Schultz Expanding the genetic repertoire of the methylotrophic yeast Pichia pastoris Biochemistry 48 2009 2643 2653
72. M. Aslam, and S.J. Perkins Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering. Analytical ultracentrifugation and constrained molecular modelling J. Mol. Biol. 309 2001 1117 1138
73. P.J. Lachmann The amplification loop of the complement pathways Adv. Immunol. 104 2010 115 149